Alphatec Holdings Financials
| ATEC Stock | USD 12.06 0.61 5.33% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 2.58 |
|
|
Investors should never underestimate Alphatec Holdings' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Alphatec Holdings' cash flow, debt, and profitability to make informed and accurate decisions about investing in Alphatec Holdings.
Net Income |
|
Alphatec | Select Account or Indicator |
Understanding current and past Alphatec Holdings Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Alphatec Holdings' financial statements are interrelated, with each one affecting the others. For example, an increase in Alphatec Holdings' assets may result in an increase in income on the income statement.
Please note, the presentation of Alphatec Holdings' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Alphatec Holdings' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Alphatec Holdings' management manipulating its earnings.
Alphatec Holdings Stock Summary
Alphatec Holdings competes with Globus Medical, Orthofix Medical, CONMED, LivaNova PLC, and Orthopediatrics Corp. Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company was founded in 1990 and is headquartered in Carlsbad, California. Alphatec Holdings operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 561 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US02081G2012 |
| CUSIP | 02081G201 02081G102 |
| Location | California; U.S.A |
| Business Address | 1950 Camino Vida |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.atecspine.com |
| Phone | 760 431 9286 |
| Currency | USD - US Dollar |
Alphatec Holdings Key Financial Ratios
| Return On Equity | -211.37 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.20) % | ||||
| Price To Sales | 2.83 X | ||||
| Revenue | 482.26 M |
Alphatec Holdings Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 261.2M | 572.1M | 513.4M | 805.2M | 926.0M | 972.3M | |
| Net Debt | (102.7M) | (182.7M) | 311.2M | 320.7M | 368.8M | 387.3M | |
| Cash | 107.8M | 187.2M | 84.7M | 221.0M | 254.1M | 266.8M | |
| Other Assets | 1.8M | 3.2M | 4.9M | 1.0 | 0.9 | 0.86 | |
| Total Liab | 131.3M | 492.6M | 550.1M | 703.5M | 809.0M | 849.5M | |
| Total Current Assets | 184.2M | 331.2M | 255.6M | 451.1M | 518.8M | 544.7M | |
| Other Current Liab | 397K | 55.5M | 65.6M | 85.7M | 98.6M | 103.5M | |
| Other Liab | 12.0M | 8.6M | 367.9M | 11.5M | 13.3M | 12.6M | |
| Retained Earnings | (638.0M) | (782.3M) | (934.5M) | (1.1B) | (1.0B) | (956.7M) | |
| Accounts Payable | 17.6M | 25.7M | 34.7M | 49.0M | 56.3M | 59.1M | |
| Long Term Debt | 38.0M | 326.5M | 349.5M | 511.0M | 587.7M | 617.1M | |
| Net Receivables | 24.6M | 41.9M | 60.1M | 72.6M | 83.5M | 87.7M | |
| Inventory | 46.0M | 91.7M | 101.5M | 136.8M | 157.4M | 165.2M | |
| Other Current Assets | 5.4M | 10.3M | 9.4M | 20.7M | 23.8M | 25.0M | |
| Short Term Debt | 5.1M | 4.6M | 24.6M | 7.0M | 8.0M | 10.0M | |
| Intangible Assets | 24.7M | 85.3M | 82.8M | 102.5M | 117.8M | 123.7M | |
| Net Tangible Assets | 28.7M | 114.9M | (45.5M) | (159.3M) | (143.3M) | (136.2M) | |
| Long Term Debt Total | 42.3M | 53.4M | 38.0M | 326.5M | 375.5M | 394.2M | |
| Capital Surpluse | 523.5M | 606.6M | 770.8M | 892.8M | 1.0B | 593.3M |
Alphatec Holdings Key Income Statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 12.4M | 7.1M | 5.5M | 16.6M | 19.1M | 20.1M | |
| Total Revenue | 144.9M | 243.2M | 350.9M | 482.3M | 554.6M | 582.3M | |
| Gross Profit | 102.5M | 157.8M | 233.1M | 310.2M | 356.7M | 374.6M | |
| Operating Income | (46.1M) | (108.9M) | (121.1M) | (173.4M) | (156.1M) | (148.3M) | |
| Ebit | (66.5M) | (137.1M) | (146.5M) | (170.3M) | (153.2M) | (145.6M) | |
| Research Development | 18.7M | 32.0M | 44.0M | 70.1M | 80.6M | 84.7M | |
| Ebitda | (54.8M) | (106.9M) | (102.6M) | (110.6M) | (99.5M) | (94.6M) | |
| Cost Of Revenue | 42.4M | 85.5M | 117.8M | 172.1M | 197.9M | 207.8M | |
| Income Before Tax | (78.8M) | (144.2M) | (152.0M) | (186.9M) | (168.2M) | (159.8M) | |
| Net Income | (79.0M) | (144.3M) | (152.1M) | (186.6M) | (168.0M) | (159.6M) | |
| Income Tax Expense | 145K | 164K | 140K | (277K) | (249.3K) | (261.8K) | |
| Non Recurring | 2.4M | 60K | 4.2M | 8.1M | 7.3M | 6.9M | |
| Tax Provision | 145K | 164K | 140K | 179K | 205.9K | 216.1K |
Alphatec Holdings Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (18.2M) | (27.7M) | (20.7M) | (45.6M) | (41.0M) | (39.0M) | |
| Change In Cash | 60.7M | 79.5M | (102.6M) | 136.3M | 156.7M | 164.6M | |
| Free Cash Flow | (70.3M) | (142.0M) | (133.4M) | (165.5M) | (148.9M) | (141.5M) | |
| Depreciation | 11.6M | 30.2M | 43.9M | 59.7M | 68.6M | 72.1M | |
| Other Non Cash Items | 19.2M | 4.6M | 15.6M | 21.4M | 24.6M | 18.4M | |
| Capital Expenditures | 23.9M | 68.5M | 58.3M | 87.0M | 100.0M | 105.0M | |
| Net Income | (79.0M) | (144.3M) | (152.1M) | (186.6M) | (168.0M) | (159.6M) | |
| End Period Cash Flow | 107.8M | 187.2M | 84.7M | 221.0M | 254.1M | 266.8M | |
| Investments | (23.9M) | (3M) | (58.3M) | (128.6M) | (115.7M) | (110.0M) | |
| Change Receivables | (396K) | (1.3M) | (7.5M) | (10.1M) | (9.1M) | (8.7M) | |
| Net Borrowings | 8.4M | 19.8M | 306.2M | 35M | 40.3M | 32.7M | |
| Change To Netincome | 21.8M | 31.5M | 59.9M | 54.1M | 62.2M | 33.7M |
Alphatec Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alphatec Holdings's current stock value. Our valuation model uses many indicators to compare Alphatec Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alphatec Holdings competition to find correlations between indicators driving Alphatec Holdings's intrinsic value. More Info.Alphatec Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Alphatec Holdings' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alphatec Holdings' earnings, one of the primary drivers of an investment's value.Alphatec Holdings Systematic Risk
Alphatec Holdings' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Alphatec Holdings volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Alphatec Holdings correlated with the market. If Beta is less than 0 Alphatec Holdings generally moves in the opposite direction as compared to the market. If Alphatec Holdings Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Alphatec Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Alphatec Holdings is generally in the same direction as the market. If Beta > 1 Alphatec Holdings moves generally in the same direction as, but more than the movement of the benchmark.
About Alphatec Holdings Financials
What exactly are Alphatec Holdings Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Alphatec Holdings' income statement, its balance sheet, and the statement of cash flows. Potential Alphatec Holdings investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Alphatec Holdings investors may use each financial statement separately, they are all related. The changes in Alphatec Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alphatec Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Alphatec Holdings Thematic Clasifications
Alphatec Holdings is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Today, most investors in Alphatec Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alphatec Holdings' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Alphatec Holdings growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Alphatec Holdings January 29, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Alphatec Holdings help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alphatec Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alphatec Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Alphatec Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alphatec Holdings's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.24 | |||
| Information Ratio | 0.192 | |||
| Maximum Drawdown | 19.68 | |||
| Value At Risk | (4.58) | |||
| Potential Upside | 7.91 |
Complementary Tools for Alphatec Stock analysis
When running Alphatec Holdings' price analysis, check to measure Alphatec Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alphatec Holdings is operating at the current time. Most of Alphatec Holdings' value examination focuses on studying past and present price action to predict the probability of Alphatec Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alphatec Holdings' price. Additionally, you may evaluate how the addition of Alphatec Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |